Basal Septal T1 Mapping and Extracellular Volume As Discriminators in Cardiac Magnetic Resonance Evaluation of Myocardial Involvement in Advanced Anderson-Fabry Disease: a Case Description

Overview

Journal Quant Imaging Med Surg

Specialty Radiology

Date 2023 Dec 18

PMID 38106323

Authors

Yaqi Du

Ruoshi Liu

Shuang Ding

Guan Wang

Affiliations

Soon will be listed here.

References

Linhart A, Palecek T, Bultas J, Ferguson J, Hrudova J, Karetova D . New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J. 2000; 139(6):1101-8. DOI: 10.1067/mhj.2000.105105. View

Kaul S, Hopkins J, Shah P . Chronic effects of myocardial infarction on right ventricular function: a noninvasive assessment. J Am Coll Cardiol. 1983; 2(4):607-15. DOI: 10.1016/s0735-1097(83)80299-x. View

Mehta A, Clarke J, Giugliani R, Elliott P, Linhart A, Beck M . Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet. 2009; 46(8):548-52. DOI: 10.1136/jmg.2008.065904. View

Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H . Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004; 109(10):1250-8. DOI: 10.1161/01.CIR.0000118493.13323.81. View

Wilson H, Ambach S, Madueme P, Khoury P, Hopkin R, Jefferies J . Comparison of Native T1, Strain, and Traditional Measures of Cardiovascular Structure and Function by Cardiac Magnetic Resonance Imaging in Patients With Anderson-Fabry Disease. Am J Cardiol. 2018; 122(6):1074-1078. DOI: 10.1016/j.amjcard.2018.06.007. View

Pieroni M, Moon J, Arbustini E, Barriales-Villa R, Camporeale A, Cokan Vujkovac A . Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2021; 77(7):922-936. DOI: 10.1016/j.jacc.2020.12.024. View

Augusto J, Nordin S, Vijapurapu R, Baig S, Bulluck H, Castelletti S . Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease. Circ Cardiovasc Imaging. 2020; 13(3):e010171. DOI: 10.1161/CIRCIMAGING.119.010171. View

Sheppard M, Cane P, Florio R, Kavantzas N, Close L, Shah J . A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy. Cardiovasc Pathol. 2009; 19(5):293-301. DOI: 10.1016/j.carpath.2009.05.003. View

Bernardini A, Camporeale A, Pieroni M, Pieruzzi F, Figliozzi S, Lusardi P . Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy. JACC Cardiovasc Imaging. 2020; 13(10):2262-2264. DOI: 10.1016/j.jcmg.2020.05.011. View

10.

Sado D, White S, Piechnik S, Banypersad S, Treibel T, Captur G . Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013; 6(3):392-8. DOI: 10.1161/CIRCIMAGING.112.000070. View

11.

Deva D, Hanneman K, Li Q, Ng M, Wasim S, Morel C . Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease. J Cardiovasc Magn Reson. 2016; 18:14. PMC: 4818406. DOI: 10.1186/s12968-016-0233-6. View

12.

Figliozzi S, Camporeale A, Boveri S, Pieruzzi F, Pieroni M, Lusardi P . ECG-based score estimates the probability to detect Fabry Disease cardiac involvement. Int J Cardiol. 2021; 339:110-117. DOI: 10.1016/j.ijcard.2021.07.022. View

13.

Camporeale A, Moroni F, Lazzeroni D, Garibaldi S, Pieroni M, Pieruzzi F . Trabecular complexity as an early marker of cardiac involvement in Fabry disease. Eur Heart J Cardiovasc Imaging. 2021; 23(2):200-208. DOI: 10.1093/ehjci/jeaa354. View

14.

Linhart A, Germain D, Olivotto I, Akhtar M, Anastasakis A, Hughes D . An expert consensus document on the management of cardiovascular manifestations of Fabry disease. Eur J Heart Fail. 2020; 22(7):1076-1096. DOI: 10.1002/ejhf.1960. View

15.

Perry R, Shah R, Saiedi M, Patil S, Ganesan A, Linhart A . The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease. JACC Cardiovasc Imaging. 2019; 12(7 Pt 1):1230-1242. DOI: 10.1016/j.jcmg.2018.11.039. View

16.

Thurberg B, Fallon J, Mitchell R, Aretz T, Gordon R, OCallaghan M . Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy. Circulation. 2009; 119(19):2561-7. DOI: 10.1161/CIRCULATIONAHA.108.841494. View